Head & Neck Cancer section

Head and Neck Cancer News & Features

What are Medicare costs for patients with oral cavity and pharyngeal cancers?

The Medicare costs for older patients with oral cavity and pharyngeal cancers have increased due to several factors, including on demographics, treatment selection, and co-existing illnesses.

Certain HPV16 antibodies may predict oropharyngeal cancer survival

Certain HPV16 antibodies may predict oropharyngeal cancer survival

Certain human papillomavirus (HPV)-16 antibodies in the blood associated with improved survival in HPV-related oropharyngeal carcinoma.

Pactomycin analogs offer new, gentler approach to cancer treatment

Two promising analogs of an old compound originally studied as a potent antitumor agent may offer a new treatment for epithelial cancer.

PET-CT Surveillance Cost-Effective for Locally Advanced Head and Neck Squamous Cell Cancer

PET-CT Surveillance Cost-Effective for Locally Advanced Head and Neck Squamous Cell Cancer

PET-CT guided active surveillance for patients with locally advanced head and neck squamous cell cancer is an option over node dissection, per analysis data presented at the 2015 American Society of Clinical Oncology annual meeting.

MEDI4736 Shows Consistent Safety Response in Head and Neck Squamous Cell Carcinoma

MEDI4736 Shows Consistent Safety Response in Head and Neck Squamous Cell Carcinoma

Safety profile of MEDI4736 in patients with squamous cell carcinoma of the head and neck is manageable.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs